Genetic Technology Alert. Developing Therapeutics Using Genome Editing Technology; Usage of CRISPR/Cas9 can Affect Agriculture and Industrial Biotechnology Industries; Rapid Adoption and Expansion of Genome Editing across Therapeutic Developments

USD 250

* Required Fields

USD 250

PAY BY INVOICE

Be the first to review this product

This issue profiles developing therapeutics using genome editing technology, impact of usage of CRISPR/Cas9 on agriculture and industrial biotechnology industries, rapid adoption and expansion of genome editing across therapeutic developments.

Table of Contents

Genetic Technology Alert. Developing Therapeutics Using Genome Editing Technology; Usage of CRISPR/Cas9 can Affect Agriculture and Industrial Biotechnology Industries; Rapid Adoption and Expansion of Genome Editing across Therapeutic DevelopmentsIn This Issue1. DEVELOPING THERAPEUTICS USING GENOME EDITING TECHNOLOGY2. USAGE OF CRISPR/Cas9 CAN AFFECT AGRICULTURE AND INDUSTRIAL BIOTECHNOLOGY INDUSTRIES3. RAPID ADOPTION AND EXPANSION OF GENOME EDITING ACROSS THERAPEUTIC DEVELOPMENTS4. PATENT DISPUTE FOR CRISPR/Cas95. TECHVISION 2015




Related Research

Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.